drugset
Drugs / hTERT I540/R572Y/D988Y multipeptide vaccine
last change Feb 2009 re-read 2 minutes ago

hTERT I540/R572Y/D988Y multipeptide vaccine

Vaccine

Developed for
plasma cell myeloma
Investigated by
National Cancer Institute (NCI) · University of Maryland Greenebaum Cancer Center

Trials 1 · a red edge is where a trial was stopped

today NCT00499577 · Ph 1/2
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00499577 Dec 2006 → Feb 2009 plasma cell myeloma University of Maryland Greenebaum Cancer Center Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as hTERT I540/R572Y/D988Y multipeptide vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00499577 ↗
Modality Vaccine “hTERT I540/R572Y/D988Y multipeptide vaccine” NCT00499577 ↗
Route Subcutaneous “Given subcutaneously” NCT00499577 ↗